Active surveillance (AS) is a treatment strategy for prostate cancer (PCa) whereby patients diagnosed with PCa undergo ongoing characterization of their disease with the intent of avoiding radical treatment.
Previously, AS has been demonstrated to be a reasonable option for men with low-risk PCa, but existing cohorts largely consist of Caucasian Americans. Because African Americans have a greater incidence, more aggressive, and potentially more lethal PCa than Caucasian Americans, it is unclear if AS is appropriate for African Americans. We performed a review of the available literature on AS with a focus on African Americans.
Written by:
Silberstein JL, Feibus AH, Maddox MM, Abdel-Mageed AB, Moparty K, Thomas R, Sartor O. Are you the author?
Department of Urology, Tulane University School of Medicine, New Orleans, LA; Department of Hematology and Medical Oncology, Tulane University School of Medicine, New Orleans, LA.
Reference: Urology. 2014 Oct 2. pii: S0090-4295(14)00832-2.
doi: 10.1016/j.urology.2014.06.064
PubMed Abstract
PMID: 25283702